Research

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

 

Preenie deS Senanayake, Ph.D.

  1. Mawer B, Blackhouse J, Hill LF, Lumb GA, DeSilva P, Taylor CM, Stanbury SW. Vitamin D metabolism and parathyroid function in man. Clin Sci Mol Med 48: 349-365, 1975.
  2. Stanbury SW, Torkington P, Lumb GA, Adams PH, DeSilva P, Taylor CM. Asian rickets and osteomalacia - Patterns of parathyroid responses in Vitamin D deficiency. In: Proceedings of Nutritional Society 34: 111-117, 1975.
  3. Stanbury SW, Mawer B, Hill LF, Lumb GA, DeSilva P. Vitamin D Metabolism in Man. Observations on the formation of 1,25-dihydroxycholecalciferol. (Eds, AW Norman, K Schafer, HG Grigoleit, D Herrath, E Ritz), 1975, pp 205-218, de Gruyter, Berlin, New York.
  4. Stanbury SW, Mawer EB, Hill LF, Taylor CM, DeSilva P, Lumb GA. Vitamin D Metabolism in Health and Disease. In: Calcium Regulating Hormones (Ed. Talmage RV, Owen M and Parson JA), 1985, 431-438 Excerpta Medica, Amsterdam.
  5. Taylor CM, Hughes S, DeSilva P. Competitive protein binding assay of 24,25-dihydroxycholecalciferol. Biochem Biophys Res Commun 70: 1243-1249, 1976.
  6. Taylor CM, DeSilva P, Hughes S. Competitive protein binding assay of 24,25-dihydroxy Vitamin D. J Endocrin 24: 40-44, 1976.
  7. Khokhar AM, DeSilva P, Havard CWH, Bird R, Foraling ML, Slater JDH. Mechanisms of exercise mediated vasopressin release in man. In: Proceedings of the European Society of Clinical Investigations, 1979.
  8. Stanbury SW, Mawer EB, Taylor CM, DeSilva P. The skin, vitamin D and the control of its 25-hydroxylation. Mineral Electrolyte Metabolism 3: 51-60, 1980.
  9. White M, DeSilva P, Havard CWH. Plasma pyridostigmine levels in myasthenia gravis. Neurology 31: 145-150, 1981.
  10. Suzuki H, Ferrario CM, Speth RC, Brosnihan KB, Smeby RR, DeSilva P. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension 5 (Suppl I): I-140, 1983.
  11. Suzuki H, Smeby RR, Mikami H, Brosnihan KB, Husain A, DeSilva P, Saruta T, Ferrario CM. Non-renal factors contribute to plasma and cerebrospinal fluid angiotensin II. Hypertension 8 (Suppl I):1-95-I-100, 1986.
  12. Husain A, Bumpus FM, DeSilva P, Speth RC. Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries. Proc Natl Acad Sci USA 84:2489-2493, 1987.
  13. Husain A, DeSilva P, Speth RC, Bumpus FM. Regulation of angiotensin II in rat adrenal gland. Circ Res 60: 640-647, 1987.
  14. DeSilva P, Husain A, Smeby RR and Khairallah PA. Measurement of immunoreactive angiotensin peptides in rat tissues: Some pitfalls in angiotensin II analysis. Analytical Biochemistry 174: 80-87, 1988. (The above publications are published under DeSilva P)
  15. Senanayake P, Warner MW, Levy MN, Jacobsen DW, Ferrario CM. Characterization of neuropeptide Y-immunoreactivity in dog plasma by high-performance liquid chromatography and radioimmunoassay. Annals of the New York Academy of Sciences 611: 340-342, 1990.
  16. Warner MW, Senanayake P, Ferrario CM, Levy MN. Sympathetic stimulation-evoked overflow of neuropeptide Y and norinephrine from the heart. Annals of the New York Academy of Sciences 611:404, 1990.
  17. Warner MW, Senanayake P, Ferrario CM, Levy MN. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. Circ Res 69:455-465, 1991.
  18. Kohara K, Tabuchi Y, Senanayake PdeS, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 12:1135-1141, 1991.
  19. Senanayake PdeS, Warner MR, Brosnihan KB, Levy MN, Ferrario CM. Circulating neuropeptide Y in dog plasma consists of multiple peptide fragments. Peptides 13:1165-1173, 1992.
  20. Clark JW, Senanayake PdeS, Solomon GD, Gallagher C. Substance P: Correlation of CSF and plasma levels. Headache 34: 261-264, 1994.
  21. Senanayake PdeS, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 15: 919-926, 1994.
  22. Solomon GD, Clark JW, Senanayake PdeS. Substance P on post lumbar-puncture headache. In: New Advances in Headache Research (Ed. FC Rose), 1994, pp 97-101: H Smith Gordon & Co, London.
  23. Solomon GD, Clark JW, Senanayake PdeS, Kunkel RS. Hypersensitivity to Substance P in the etiology of post lumbar puncture headache. Headache 35: 25-28, 1995.
  24. Senanayake PdeS, Kincade-Denker J, Bravo EL, Graham RM. Production, characterization and expression of neuropeptide Y by human pheochromocytoma. J Clin Invest 96:2503-2509, 1995.
  25. Clark JW, Solomon GD, Senanayake PD, Gallagher C. Substance P concentration and history of headache in relation to postlumbar puncture headache: towards prevention. Journal of Neurology, Neurosurgery & Psychiatry 60(6):681-3, June 1996
  26. Senanayake PdeS, Smeby RR, Martins AS, Moriguchi A, Kumagai H, Ganten D, Brosnihan KB. Adrenal, Kidney, and Heart Angiotensins in Female Murine Ren-2 Transfected Hypertensive Rats. Peptides 19:1685-1694,1998.
  27. Brosnihan KB, Li P, Senanayake PdeS, Ferrario CM. Bi-directional actions of estrogen on the renin-angiotensin system. Braz J Med Biol Res 32: 373-381,1999.
  28. Senanayake PdeS, Calabro A, K Nishiyama, Hu JG, Bok D, Hollyfield JH. Glycosamionglycan synthesis and secretion by the retinal pigment epithelium: polarized delivery of hyaluronan from the apical surface. Journal of Cell Science 114: 199-205,2000.
  29. EM Alberti, JE Weldon, Senanayake PdeS, Hollyfield JH, SP Becerra. The role of glycosaminoglycans on pigment epithelium-derived factor (PEDF): Heparin sulfate enhances binding to cell-surface receptors. (Glyobilogy - In review)